Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CTR20262749 Lansoprazole/Sodium Bicarbonate Esophagitis, Peptic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262749 clinical trial report covering Lansoprazole/Sodium Bicarbonate, Phase 1, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
ChiCTR2600128259 ZX2021 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600128259 clinical trial report covering ZX2021, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708116 CTX-187 Bronchiectasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708116 clinical trial report covering CTX-187, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708428 LG-0317 Herpesviridae Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708428 clinical trial report covering LG-0317, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07706686 rDEN2delta30-7169 vaccine(National Institute of Allergy & Infectious Diseases) Dengue Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07706686 clinical trial report covering rDEN2delta30-7169 vaccine(National Institute of Allergy & Infectious Diseases), Phase 1, endpoints, sponsor, geo
Latest Hotspot
8 min read
NCT07708493 BI-3034701 Overweight Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708493 clinical trial report covering BI-3034701, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708272 Rovadicitinib Myelofibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708272 clinical trial report covering Rovadicitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708038 Tocilizumab Kidney Failure, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708038 clinical trial report covering Tocilizumab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262765 YP004 Wet age-related macular degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262765 clinical trial report covering YP004, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262758 SY-12321 Anaplastic Large-Cell Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262758 clinical trial report covering SY-12321, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262601 Obefazimod Colitis, Ulcerative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262601 clinical trial report covering Obefazimod, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262763 Flunotinib maleate Bone Marrow Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262763 clinical trial report covering Flunotinib maleate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.